Skip to main content
. 2020 May 13;12(9):8710–8727. doi: 10.18632/aging.103197

Figure 7.

Figure 7

Soy isoflavones increase PGC1-alpha activity in hypothalamic cell line. (A) Quantification shows the mRNA levels of PGC1-alpha, SOD2 and GPx were increased under daidzein(50μM) and genistein(50μM) treatment for 24h in N42 cells; (B, C) Western blots and quantification show the protein levels of PGC1-alpha, SOD2 and GPx were increased under daidzein(50μM) and genistein(50μM) treatment for 24h in N42 cells; (D–F) Western blots and quantification show the SR-18292(20μM) administration inhibited the protein levels of SOD2 and GPx induced by daidzein and genistein treatment in N42 cells. (G, H) Western blots and quantification show the PA(100μM) administration inhibited the protein levels of PGC1-alpha, SOD2 and GPx, while daidzein and genistein could abolish the inhibition of PA in N42 cells. ns, no statistical significance, * p < 0.05, ** p < 0.01, ***p < 0.001.